Chronic pain makes many sufferers contemplate suicide
ViroPharma Inc. has announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Cinryze C1 Inhibitor (human) as a treatment for acute attacks of hereditary angioedema (HAE). The sBLA is based on a re-analysis and resubmission of data from a pivotal Phase 3 acute treatment
Full Post: ViroPharma Inc. submits sBLA for Cinryze to treat acute attacks of hereditary angioedema
According to new research patients suffering chronic pain are more likely than others to consider suicide.
A study by researchers in the United States found this increased risk remained even when the possible effect of mental illness was accounted for and the researchers say it provides further evidence of the need to be aware of the heightened risk for suicide in those with chronic pain.
Lead study author Dr. Mark Ilgen, says the research shows that more work needs to be done in identifying those likely to be at the greatest risk and what interventions will decrease this risk.
The study by Dr. Ilgen and his colleagues set out to gain a perspective on the link between pain and suicide amongst the public as most research had only examined the issue in patients already receiving treatment for their pain.
Dr. Ilgen, a psychologist at the Ann Arbor VA Hospital and assistant professor at the University of Michigan, says pain is one of those factors that may make someone feel more hopeless and less optimistic about the future and increases the chances that they will think about suicide, but the vast majority of people experiencing any of these forms of pain are not suicidal.
For the study the researchers examined information collected during a 2001 to 2003 epidemiological survey of 5,692 English-speaking adults in the United States who answered questions about chronic pain and suicidal thoughts in the last 12 months.
They found after adjusting the figures to account for the effect of mental illness and chronic physical conditions, that those who suffered from head pain were almost twice as likely as others to report having suicidal thoughts and were also more than two times as likely to report suicide attempts.
The researchers also found that those with other types of pain not related to arthritis were four times as liable to have tried to commit suicide and almost 14% of those with three or more pain conditions reported suicidal thoughts - almost 6% of these also reported a suicide attempt.
Experts say people accustomed to pain might think they could tolerate suicide but the natural and deep fear of pain, injury and death stops people from hurting themselves, and this includes people who have high desire for suicide and this might not be as difficult for someone who has already had to contend with a great deal of physical pain.
This say such a view attracts little attention because in the public mind, a kind of fearlessness does not seem to fit with suicide but in this case the public mind is mistaken
The study findings appear in the November/December issue of the journal General Hospital Psychiatry.
The U.S. Food and Drug Administration has announced it will require the manufacturers of antiepileptic drugs to add to these products’ prescribing information, or labeling, a warning that their use increases risk of suicidal thoughts and behaviors (suicidality). The action includes all antiepileptic drugs including those used to treat psychiatric disorders, migraine headaches and other
Full Post: FDA requires stronger warnings on antiepileptic medicines
Eli Lilly and Company has withdrawn its supplemental New Drug Application (sNDA) from the U.S. Food and Drug Administration (FDA) for Cymbalta (duloxetine HCl) for the management of chronic pain. Lilly plans to resubmit the application in the first half of 2009, adding data from a recently completed positive study in chronic osteoarthritis pain of
Full Post: Eli Lilly withdraws application for additional U.S. indication for Cymbalta for chronic pain
Men and women who have tried to kill themselves and are suffering from unipolar disorder (major depression), bipolar disorder (manic depression) or schizophrenia are at a very high risk of committing suicide within a year of their first attempt, concludes a study published today on bmj.com. This is the first time research has identified a
Full Post: Patients with depressive disorders or schizophrenia more likely to re-attempt suicide
If suicide among young men living with substance abuse is to be prevented it is not enough to focus on the individual client. A common warning system for paramedics, care centres and social services has to be developed according to Stian Biong, who has defended his thesis at the Nordic School of Public Health in
Full Post: Warning systems can prevent suicide among young men with substance abuse
Scientists peered at the brains of people with a baffling chronic pain condition and discovered something surprising. Their brains looked like an inept cable guy had changed the hookups, rewiring the areas related to emotion, pain perception and the temperature of their skin. The new finding by scientists at Northwestern University’s Feinberg School of Medicine,
Full Post: Baffling chronic pain linked to rewiring of brain